DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: NEWS
       *****************************************************
       #Post#: 3135--------------------------------------------------
       Updated guidelines on risk of allergic reactions with mRNA
       COVID-19 vaccines
   DIR By: agate
       Date: December 25, 2020, 11:50 am
       ---------------------------------------------------------
       From DG Alerts (December 24, 2020)--"ACAAI Updates Guidance
       Related to Risk of Allergic Reactions with mRNA COVID-19
       Vaccines":
  HTML http://bit.ly/2WNtZiq
       A couple of parts of the article are especially noteworthy:
       --- Quote ---
       >
       - The mRNA COVID-19 vaccines should be administered in a
       healthcare setting where anaphylaxis can be treated. All
       individuals must be observed for at least 15 to 30 minutes after
       injection to monitor for any adverse reaction. All anaphylactic
       reactions should be managed immediately with epinephrine as
       first-line treatment.[/l][/l][/l]
       --- End Quote ---
       [emphasis added]
       
       [li]
       And:
       [quote][/q][/q]
       - The mRNA COVID-19 vaccines are not live vaccines and can be
       administered to immunocompromised patients. Physicians and other
       providers should inform such immunocompromised patients of the
       possibility of a diminished immune response to the vaccines.[/l]
       
       [li]
       [Emphasis added]
       [/li]
       *****************************************************
       Page 1 of 1